Patent · US Active

Antibodies to PD-1 and uses thereof

US10654929B2 · kind B2 · utility

0Cited by

10References

36Claims

0Family size

Assignee

Jounce Therapeutics, Inc. · US

Inventors

George Robert Mabry, III · Needham, US
Stephen Sazinsky · Melrose, US

Key dates

Filing date	Nov 1, 2017
Grant date	May 19, 2020
Priority date	—
Expiry date	Jun 28, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are various embodiments relating to antibodies. Some of the embodiments include antagonist antibodies that bind PD-1. Such antibodies can be used in methods to treat, for example, cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.